Moreno S - Search Results

1

Durability of first-line antiretroviral regimens in the era of integrase inhibitors: a cohort of HIV-positive individuals in Spain, 2014-2015.

Jarrin I, Suarez-Garcia I, Moreno C, Tasias M, Del Romero J, Palacios R, Peraire J, Gorgolas M, Moreno S; Cohort of the Spanish HIV/AIDS Research Network (CoRIS). Jarrin I, et al. Among authors: moreno c, moreno s. Antivir Ther. 2019;24(3):167-175. doi: 10.3851/IMP3297. Antivir Ther. 2019. PMID: 30747107

2

Phenotype or virtual phenotype for choosing antiretroviral therapy after failure: a prospective, randomized study.

Perez-Elias MJ, Garcia-Arota I, Muñoz V, Santos I, Sanz J, Abraira V, Arribas JR, González J, Moreno A, Dronda F, Antela A, Pumares M, Martí-Belda P, Casado JL, Geijos P, Moreno S; Realvirfen study group. Perez-Elias MJ, et al. Among authors: moreno s, moreno a. Antivir Ther. 2003 Dec;8(6):577-84. Antivir Ther. 2003. PMID: 14760891 Clinical Trial.

3

High rate of didanosine-related mitochondrial toxicity in HIV/HCV-coinfected patients receiving ribavirin.

Moreno A, Quereda C, Moreno L, Perez-Elías MJ, Muriel A, Casado JL, Antela A, Dronda F, Navas E, Bárcena R, Moreno S. Moreno A, et al. Among authors: moreno s, moreno l. Antivir Ther. 2004 Feb;9(1):133-8. Antivir Ther. 2004. PMID: 15040545

4

Partial splenic embolization for the treatment of hypersplenism in cirrhotic HIV/HCV patients prior to pegylated interferon and ribavirin.

Moreno A, Bárcena R, Blázquez J, Quereda C, Gil-Grande L, Sánchez J, Moreno L, Perez-Elías MJ, Antela A, Moreno J, del Campo S, Moreno S. Moreno A, et al. Among authors: moreno s, moreno l, moreno j. Antivir Ther. 2004 Dec;9(6):1027-30. Antivir Ther. 2004. PMID: 15651761

5

Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir.

Llibre JM, Domingo P, Palacios R, Santos J, Pérez-Elías MJ, Sánchez-de la Rosa R, Miralles C, Antela A, Moreno S; Lipo-Rec Study Group. Llibre JM, et al. Among authors: moreno s. AIDS. 2006 Jun 26;20(10):1407-14. doi: 10.1097/01.aids.0000233574.49220.de. AIDS. 2006. PMID: 16791015

6

Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain.

Rodríguez-Arenas MA, Jarrín I, del Amo J, Iribarren JA, Moreno S, Viciana P, Peña A, Sirvent JL, Vidal F, Lacruz J, Gutierrez F, Oteo JA, Asencio R, Castilla J, Hoyos SP; CoRIS-MD. Rodríguez-Arenas MA, et al. Among authors: moreno s. AIDS Res Hum Retroviruses. 2006 Aug;22(8):715-23. doi: 10.1089/aid.2006.22.715. AIDS Res Hum Retroviruses. 2006. PMID: 16910826

7

Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to HAART and impact on mortality.

Sobrino-Vegas P, García-San Miguel L, Caro-Murillo AM, Miró JM, Viciana P, Tural C, Saumoy M, Santos I, Sola J, del Amo J, Moreno S; CoRIS. Sobrino-Vegas P, et al. Among authors: moreno s. Curr HIV Res. 2009 Mar;7(2):224-30. doi: 10.2174/157016209787581535. Curr HIV Res. 2009. PMID: 19275591

8

The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals.

HIV-CAUSAL Collaboration; Ray M, Logan R, Sterne JA, Hernández-Díaz S, Robins JM, Sabin C, Bansi L, van Sighem A, de Wolf F, Costagliola D, Lanoy E, Bucher HC, von Wyl V, Esteve A, Casbona J, del Amo J, Moreno S, Justice A, Goulet J, Lodi S, Phillips A, Seng R, Meyer L, Pérez-Hoyos S, García de Olalla P, Hernán MA. HIV-CAUSAL Collaboration, et al. Among authors: moreno s. AIDS. 2010 Jan 2;24(1):123-37. doi: 10.1097/QAD.0b013e3283324283. AIDS. 2010. PMID: 19770621 Free PMC article.

9

Risk factors, CD4 long-term evolution and mortality of HIV-infected patients who persistently maintain low CD4 counts, despite virological response to HAART.

Pacheco YM, Jarrín I, Del Amo J, Moreno S, Iribarren JA, Viciana P, Parra J, Gomez-Sirvent JL, Gutierrez F, Blanco JR, Vidal F, Leal M; CoRIS-MD. Pacheco YM, et al. Among authors: moreno s. Curr HIV Res. 2009 Nov;7(6):612-9. doi: 10.2174/157016209789973673. Curr HIV Res. 2009. PMID: 19929797

10

[HIV infection in different age groups: Potential implications for prevention. CoRIS Cohort, Spain, 2004-2008].

Caro-Murillo AM, Gil Luciano A, Navarro Rubio G, Leal Noval M, Blanco Ramos JR; Cohorte de la Red de Investigación en Sida (CoRIS). Caro-Murillo AM, et al. Med Clin (Barc). 2010 Apr 24;134(12):521-7. doi: 10.1016/j.medcli.2009.09.053. Epub 2010 Mar 6. Med Clin (Barc). 2010. PMID: 20207371 Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,037 results

Search Page

Filters